These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29672195)

  • 21. Periostin promotes malignant potential by induction of epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma.
    Mino M; Kanno K; Okimoto K; Sugiyama A; Kishikawa N; Kobayashi T; Ono J; Izuhara K; Kobayashi T; Ohigashi T; Ohdan H; Tazuma S
    Hepatol Commun; 2017 Dec; 1(10):1099-1109. PubMed ID: 29404445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase.
    Chang RM; Yang H; Fang F; Xu JF; Yang LY
    Hepatology; 2014 Oct; 60(4):1251-63. PubMed ID: 24825302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4.
    Dou C; Liu Z; Xu M; Jia Y; Wang Y; Li Q; Yang W; Zheng X; Tu K; Liu Q
    Cancer Lett; 2016 Oct; 381(2):380-90. PubMed ID: 27544906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-144-3p suppresses gastric cancer progression by inhibiting epithelial-to-mesenchymal transition through targeting PBX3.
    Li B; Zhang S; Shen H; Li C
    Biochem Biophys Res Commun; 2017 Mar; 484(2):241-247. PubMed ID: 28111340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced selenium-binding protein 1 correlates with a poor prognosis in intrahepatic cholangiocarcinoma and promotes the cell epithelial-mesenchymal transition.
    Zhang XY; Gao PT; Yang X; Cai JB; Ding GY; Zhu XD; Ji Y; Shi GM; Shen YH; Zhou J; Fan J; Sun HC; Yang LX; Huang C
    Am J Transl Res; 2018; 10(11):3567-3578. PubMed ID: 30662608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-1202 functions as a tumor suppressor in glioma cells by targeting Rab1A.
    Quan Y; Song Q; Wang J; Zhao L; Lv J; Gong S
    Tumour Biol; 2017 Apr; 39(4):1010428317697565. PubMed ID: 28443461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection.
    Huang C; Tian Y; Peng R; Zhang C; Wang D; Han S; Jiao C; Wang X; Zhang H; Wang Y; Li X
    J Gastroenterol Hepatol; 2015 Feb; 30(2):421-33. PubMed ID: 25168293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual regulatory role of CCNA2 in modulating CDK6 and MET-mediated cell-cycle pathway and EMT progression is blocked by miR-381-3p in bladder cancer.
    Li J; Ying Y; Xie H; Jin K; Yan H; Wang S; Xu M; Xu X; Wang X; Yang K; Zheng X; Xie L
    FASEB J; 2019 Jan; 33(1):1374-1388. PubMed ID: 30138038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-31 promotes oncogenesis in intrahepatic cholangiocarcinoma cells via the direct suppression of RASA1.
    Hu C; Huang F; Deng G; Nie W; Huang W; Zeng X
    Exp Ther Med; 2013 Nov; 6(5):1265-1270. PubMed ID: 24223656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-203a-3p Inhibits Pancreatic Cancer Cell Proliferation, EMT, and Apoptosis by Regulating SLUG.
    An N; Zheng B
    Technol Cancer Res Treat; 2020; 19():1533033819898729. PubMed ID: 32301392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.
    Wang LJ; He CC; Sui X; Cai MJ; Zhou CY; Ma JL; Wu L; Wang H; Han SX; Zhu Q
    Oncotarget; 2015 Mar; 6(8):5932-46. PubMed ID: 25803229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma.
    Okamoto K; Tajima H; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Harada S; Wakayama T; Iseki S; Ohta T
    Int J Oncol; 2012 Aug; 41(2):573-82. PubMed ID: 22664794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
    He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
    Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-145 functions as a tumor suppressor targeting NUAK1 in human intrahepatic cholangiocarcinoma.
    Xiong X; Sun D; Chai H; Shan W; Yu Y; Pu L; Cheng F
    Biochem Biophys Res Commun; 2015 Sep; 465(2):262-9. PubMed ID: 26255969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-876-3p targets KIF20A to block JAK2/STAT3 pathway in glioma.
    Tang J; Xu J; Zhi Z; Wang X; Wang Y; Zhou Y; Chen R
    Am J Transl Res; 2019; 11(8):4957-4966. PubMed ID: 31497212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia-induced activation of Twist/miR-214/E-cadherin axis promotes renal tubular epithelial cell mesenchymal transition and renal fibrosis.
    Liu M; Liu L; Bai M; Zhang L; Ma F; Yang X; Sun S
    Biochem Biophys Res Commun; 2018 Jan; 495(3):2324-2330. PubMed ID: 29277613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenomedullin promotes intrahepatic cholangiocellular carcinoma metastasis and invasion by inducing epithelial-mesenchymal transition.
    Zhou C; Zheng Y; Li L; Zhai W; Li R; Liang Z; Zhao L
    Oncol Rep; 2015 Aug; 34(2):610-6. PubMed ID: 26043778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. H2A.Z regulates tumorigenesis, metastasis and sensitivity to cisplatin in intrahepatic cholangiocarcinoma.
    Yang B; Tong R; Liu H; Wu J; Chen D; Xue Z; Ding C; Zhou L; Xie H; Wu J; Zheng S
    Int J Oncol; 2018 Apr; 52(4):1235-1245. PubMed ID: 29532867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long Noncoding RNA MNX1 antisense RNA 1 Exerts Oncogenic Functions in Bladder Cancer by Regulating miR-218-5p/RAB1A Axis.
    Wang J; Xing H; Nikzad AA; Liu B; Zhang Y; Li S; Zhang E; Jia Z
    J Pharmacol Exp Ther; 2020 Mar; 372(3):237-247. PubMed ID: 31843814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylation-associated silencing of microRNA-129-3p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-A.
    Cui S; Zhang K; Li C; Chen J; Pan Y; Feng B; Lu L; Zhu Z; Wang R; Chen L
    Oncotarget; 2016 Nov; 7(47):78009-78028. PubMed ID: 27793005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.